Cargando…
The erythropoietin‐derived peptide ARA 284 reduces tissue wasting and improves survival in a rat model of cancer cachexia
BACKGROUND: Cancer cachexia (CC) is a severe complication during the last stages of the disease, which is characterized by the substantial loss of muscle and fat mass. Currently, there is no effective treatment of CC. Erythropoietin plays tissue‐protective role in different tissues. Based on the str...
Autores principales: | Palus, Sandra, Elkina, Yulia, Braun, Tanja, von Haehling, Stephan, Döhner, Wolfram, Anker, Stefan D., Cerami, Anthony, Brines, Michael, Springer, Jochen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9397558/ https://www.ncbi.nlm.nih.gov/pubmed/35586884 http://dx.doi.org/10.1002/jcsm.13009 |
Ejemplares similares
-
The role of myostatin in muscle wasting: an overview
por: Elkina, Yulia, et al.
Publicado: (2011) -
MT‐102 prevents tissue wasting and improves survival in a rat model of severe cancer cachexia
por: Pötsch, Mareike S., et al.
Publicado: (2020) -
Ursodeoxycholic acid treatment in a rat model of cancer cachexia
por: Tschirner, Anika, et al.
Publicado: (2011) -
IGF-1 treatment reduces weight loss and improves outcome in a rat model of cancer cachexia
por: Schmidt, Katja, et al.
Publicado: (2011) -
Febuxostat improves outcome in a rat model of cancer cachexia
por: Konishi, Masaaki, et al.
Publicado: (2015)